Cancer Treatment Reviews, volume 29, issue 6, pages 515-523
Classification of anticancer drugs—a new system based on therapeutic targets
1
Servicio de Oncologı́a Médica, Hospital La Paz, Madrid, Spain
|
Publication type: Journal Article
Publication date: 2003-12-01
Journal:
Cancer Treatment Reviews
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 11.8
ISSN: 03057372
Oncology
General Medicine
Radiology, Nuclear Medicine and imaging
Abstract
The arrival of a great number of new antineoplastic agents has made it necessary to reclassify all of them. Anticancer drugs may act at different levels: cancer cells, endothelium, extracellular matrix, the immune system or host cells. The tumour cell can be targeted at the DNA, RNA or protein level. Most classical chemotherapeutic agents interact with tumour DNA, whereas monoclonal antibodies and small molecules are directed against proteins. The endothelium and extracellular matrix may be affected also by specific antibodies and small molecules.
Top-30
Journals
|
1
2
3
4
|
|
|
Bioorganic Chemistry
4 publications, 3.54%
|
|
|
Pharmaceutics
3 publications, 2.65%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.77%
|
|
|
Molecules
2 publications, 1.77%
|
|
|
Cancers
2 publications, 1.77%
|
|
|
Journal of the American Academy of Dermatology
2 publications, 1.77%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
2 publications, 1.77%
|
|
|
Future Medicinal Chemistry
1 publication, 0.88%
|
|
|
International Journal of Green Nanotechnology
1 publication, 0.88%
|
|
|
Cells
1 publication, 0.88%
|
|
|
Processes
1 publication, 0.88%
|
|
|
Applied Sciences (Switzerland)
1 publication, 0.88%
|
|
|
Frontiers in Pharmacology
1 publication, 0.88%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 0.88%
|
|
|
Catalysts
1 publication, 0.88%
|
|
|
Topics in Catalysis
1 publication, 0.88%
|
|
|
Microbial Cell Factories
1 publication, 0.88%
|
|
|
Journal of Chemical Sciences
1 publication, 0.88%
|
|
|
Scientific Reports
1 publication, 0.88%
|
|
|
npj Precision Oncology
1 publication, 0.88%
|
|
|
Nature
1 publication, 0.88%
|
|
|
Journal of Venomous Animals and Toxins Including Tropical Diseases
1 publication, 0.88%
|
|
|
Oncogene
1 publication, 0.88%
|
|
|
Egyptian Journal of Medical Human Genetics
1 publication, 0.88%
|
|
|
Computational and Theoretical Chemistry
1 publication, 0.88%
|
|
|
Journal of Molecular Structure
1 publication, 0.88%
|
|
|
Thrombosis Research
1 publication, 0.88%
|
|
|
Journal of Inorganic Biochemistry
1 publication, 0.88%
|
|
|
Nanomedicine: Nanotechnology, Biology, and Medicine
1 publication, 0.88%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
41 publications, 36.28%
|
|
|
MDPI
13 publications, 11.5%
|
|
|
Springer Nature
12 publications, 10.62%
|
|
|
Wiley
8 publications, 7.08%
|
|
|
Taylor & Francis
7 publications, 6.19%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 2.65%
|
|
|
SAGE
2 publications, 1.77%
|
|
|
Frontiers Media S.A.
2 publications, 1.77%
|
|
|
Hindawi Limited
2 publications, 1.77%
|
|
|
Future Medicine
1 publication, 0.88%
|
|
|
Centro de Estudos de Venenos e Animais Peconhentos
1 publication, 0.88%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.88%
|
|
|
King Saud University
1 publication, 0.88%
|
|
|
Academia Brasileira de Ciencias
1 publication, 0.88%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 0.88%
|
|
|
American Society of Hematology
1 publication, 0.88%
|
|
|
Asian Journal of Chemistry
1 publication, 0.88%
|
|
|
Spandidos Publications
1 publication, 0.88%
|
|
|
AIP Publishing
1 publication, 0.88%
|
|
|
IOP Publishing
1 publication, 0.88%
|
|
|
S. Karger AG
1 publication, 0.88%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.88%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Espinosa E. et al. Classification of anticancer drugs—a new system based on therapeutic targets // Cancer Treatment Reviews. 2003. Vol. 29. No. 6. pp. 515-523.
GOST all authors (up to 50)
Copy
Espinosa E., Zamora P., Feliu J., González-Barón M. Classification of anticancer drugs—a new system based on therapeutic targets // Cancer Treatment Reviews. 2003. Vol. 29. No. 6. pp. 515-523.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/s0305-7372(03)00116-6
UR - https://doi.org/10.1016/s0305-7372(03)00116-6
TI - Classification of anticancer drugs—a new system based on therapeutic targets
T2 - Cancer Treatment Reviews
AU - Espinosa, Enrique
AU - Zamora, Pilar
AU - Feliu, Jaime
AU - González-Barón, Manuel
PY - 2003
DA - 2003/12/01
PB - Elsevier
SP - 515-523
IS - 6
VL - 29
SN - 0305-7372
ER -
Cite this
BibTex
Copy
@article{2003_Espinosa,
author = {Enrique Espinosa and Pilar Zamora and Jaime Feliu and Manuel González-Barón},
title = {Classification of anticancer drugs—a new system based on therapeutic targets},
journal = {Cancer Treatment Reviews},
year = {2003},
volume = {29},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/s0305-7372(03)00116-6},
number = {6},
pages = {515--523},
doi = {10.1016/s0305-7372(03)00116-6}
}
Cite this
MLA
Copy
Espinosa, Enrique, et al. “Classification of anticancer drugs—a new system based on therapeutic targets.” Cancer Treatment Reviews, vol. 29, no. 6, Dec. 2003, pp. 515-523. https://doi.org/10.1016/s0305-7372(03)00116-6.